Cita APA (7a ed.)

M, P., C, M., A, L., & SA, S. (2016). Aptamer-hybrid nanoparticle bioconjugate efficiently delivers miRNA-29b to non-small-cell lung cancer cells and inhibits growth by downregulating essential oncoproteins. Dove Medical Press.

Cita Chicago Style (17a ed.)

M, Perepelyuk, Maher C, Lakshmikuttyamma A, y Shoyele SA. Aptamer-hybrid Nanoparticle Bioconjugate Efficiently Delivers MiRNA-29b to Non-small-cell Lung Cancer Cells and Inhibits Growth by Downregulating Essential Oncoproteins. Dove Medical Press, 2016.

Cita MLA (8a ed.)

M, Perepelyuk, et al. Aptamer-hybrid Nanoparticle Bioconjugate Efficiently Delivers MiRNA-29b to Non-small-cell Lung Cancer Cells and Inhibits Growth by Downregulating Essential Oncoproteins. Dove Medical Press, 2016.